Multiple Sclerosis News Today Forums › Forums › Trials and Research › GI Symptoms in RRMS Patients on Vumerity Fewer and Milder Than Tecfidera, Phase 3 Trial Shows

  • Trials and Research

    GI Symptoms in RRMS Patients on Vumerity Fewer and Milder Than Tecfidera, Phase 3 Trial Shows

    Posted by MS News Today Moderator on December 5, 2019 at 7:08 am

    Data from EVOLVE-MS-2 show Vumerity capsules taken twice daily caused lesser gastrointestinal discomfort than patients reported doing same with Tecfidera. Read the full story here.

    Do you take Vumerity? Does it help you?

    replied 4 years, 4 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .